Clinical Trial Update: The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial [Phase 1]

View source ↗

Summary

Phase 1 clinical trial MARCO (Microbiota Augmentation to Reestablish Commensal Organisms) investigating a microbiota-based therapy for liver diseases is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Liver Disease
• Liver Failure

Snippet

Sponsor: University of Chicago | Conditions: Liver Diseases, Liver Failure | Phase 1 | Status: RECRUITING